Hepatorenal syndrome may occur in any form of severe liver disease. It
appears less common in children than adults, but still carries a poor
prognosis. There are several factors involved in its aetiology, inclu
ding a decreased renal perfusion pressure, activation of the renal sym
pathetic nervous system and increased synthesis of several vasoactive
mediators, which may modulate glomerular filtration by acting as both
renal vasoconstrictors and dynamic regulators of the glomerular capill
ary ultrafiltration coefficient, through their action on mesangial cel
ls. This review will discuss the pathophysiology of the hepatorenal sy
ndrome and some of the principles of management of patients with renal
failure and severe liver disease. The role of renal support and liver
transplantation will also be covered.